Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,305 | 552 | 20,752 | 2,044 | 2,145 |
| Operating Income | -1,305 | -552 | -20,752 | -2,044 | -2,145 |
| Interest Expense | 133 | 132 | 131 | 130 | 120 |
| Other Income | -356 | 6 | 226 | -37 | 7 |
| Pre-tax Income | -1,793 | -679 | -20,657 | -2,211 | -2,257 |
| Income Tax | N/A | N/A | -852 | N/A | N/A |
| Net Income Continuous | -1,793 | -679 | -19,806 | -2,211 | -2,257 |
| Net Income | $-1,793 | $-679 | $-19,806 | $-2,211 | $-2,257 |
| EPS Basic Total Ops | -0.22 | -0.43 | -2.56 | -0.46 | -0.73 |
| EPS Basic Continuous Ops | -0.22 | -0.44 | -2.56 | -0.46 | -0.73 |
| EPS Diluted Total Ops | -0.22 | -0.43 | -2.56 | -0.46 | -0.73 |
| EPS Diluted Continuous Ops | -0.22 | -0.44 | -2.56 | -0.46 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -0.22 | N/A | -0.15 | -0.46 | -0.73 |
| EBITDA(a) | $-1,305 | $-552 | $-20,752 | $-2,044 | $-2,145 |